Description

14,70,000 equity shares of Shelter Pharma Limited issued on preferential basis pursuant to warrant conversion listed and permitted to trade from January 22, 2026.

Summary

BSE has listed 14,70,000 new equity shares of Shelter Pharma Limited (Scrip Code: 543963) issued through preferential allotment pursuant to warrant conversion. The shares are permitted to trade from Thursday, January 22, 2026. The shares were allotted to promoters and non-promoters at an issue price of Rs. 42.25 per share (face value Rs. 10 plus premium of Rs. 32.25) and rank pari-passu with existing equity shares.

Key Points

  • Total new shares listed: 14,70,000 equity shares of Rs. 10/- each
  • Issue type: Preferential allotment pursuant to warrant conversion
  • Issue price: Rs. 42.25 per share (Rs. 10 face value + Rs. 32.25 premium)
  • Allotment dates: 735,000 shares on 15/11/2025 and 735,000 shares on 17/11/2025
  • Distribution numbers: 14862793 to 16332792
  • ISIN: INE013V01011
  • Trading commencement: January 22, 2026
  • Ranking: Pari-passu with existing equity shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification following preferential allotment procedures.

Compliance Requirements

  • Trading members are informed to note the listing of these new securities
  • Lock-in provisions apply to the allotted shares as per the specified schedule
  • Allottees must comply with lock-in restrictions before trading locked-in shares

Important Dates

  • Allotment Date: November 15, 2025 (735,000 shares) and November 17, 2025 (735,000 shares)
  • Trading Start Date: January 22, 2026
  • Lock-in Expiry Dates:
    • 3,36,000 shares (Dist. Nos. 14862793 to 15198792): August 14, 2026
    • 3,99,000 shares (Dist. Nos. 15198793 to 15597792): August 15, 2026
    • 2,68,800 shares (Dist. Nos. 15597793 to 15866592): August 15, 2026
    • 4,66,200 shares (Dist. Nos. 15866593 to 16332792): August 15, 2027

Impact Assessment

Market Impact: Low. The listing represents approximately 14.7 lakh shares with staggered lock-in periods, limiting immediate tradable float. The preferential allotment increases the total share capital of Shelter Pharma Limited.

Shareholder Impact: Dilution effect on existing shareholders due to new share issuance. Lock-in provisions ensure gradual release of shares into the market, with majority of shares (10.03 lakh) locked until August 2026 and remaining 4.66 lakh shares locked until August 2027.

Liquidity Impact: Minimal immediate impact on liquidity due to lock-in restrictions. Tradable portion will increase progressively as lock-in periods expire in August 2026 and August 2027.

Impact Justification

Routine listing of preferential allotment shares post warrant conversion. Limited impact on broader market, primarily affects existing shareholders and allottees.